Pearl’s Second Opinion® Dental AI Platform Cleared in Turkey
Pearl , the global leader in dental AI solutions, today announced that its Second Opinion® chairside dental pathology detection aid has received clearance from the Turkish Medicines and Medical Devices Agency (TMMDA) as a Class IIa medical device.
- Pearl , the global leader in dental AI solutions, today announced that its Second Opinion® chairside dental pathology detection aid has received clearance from the Turkish Medicines and Medical Devices Agency (TMMDA) as a Class IIa medical device.
- Pearl’s AI delivers its findings in real-time for patient-facing display in the dental operatory, helping dentists ensure the accuracy of their x-ray evaluations and enabling them to better communicate diagnoses to patients.
- “At Pearl, it is our mission to equip dental practices around the world with the most clinically advanced AI on the market,” said Ophir Tanz, Founder and CEO of Pearl.
- “Designed to advance consistent high quality and doctor-patient communication, Second Opinion®’s authorization for use in Turkey will deliver the unrivaled clinical benefits of AI to one of the fastest growing dental markets in the world.”